Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes
Open Access
- 1 February 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 294 (2) , H736-H749
- https://doi.org/10.1152/ajpheart.00316.2007
Abstract
Sphingosine-1-phosphate (S1P) induces a transient bradycardia in mammalian hearts through activation of an inwardly rectifying K+current ( IKACh) in the atrium that shortens action potential duration (APD) in the atrium. We have investigated probable mechanisms and receptor-subtype specificity for S1P-induced negative inotropy in isolated adult mouse ventricular myocytes. Activation of S1P receptors by S1P (100 nM) reduced cell shortening by ∼25% (vs. untreated controls) in field-stimulated myocytes. S1P1was shown to be involved by using the S1P1-selective agonist SEW2871 on myocytes isolated from S1P3-null mice. However, in these myocytes, S1P3can modulate a somewhat similar negative inotropy, as judged by the effects of the S1P1antagonist VPC23019 . Since S1P1activates Giexclusively, whereas S1P3activates both Giand Gq, these results strongly implicate the involvement of mainly Gi. Additional experiments using the IKAChblocker tertiapin demonstrated that IKAChcan contribute to the negative inotropy following S1P activation of S1P1(perhaps through Giβγsubunits). Mathematical modeling of the effects of S1P on APD in the mouse ventricle suggests that shortening of APD (e.g., as induced by IKACh) can reduce L-type calcium current and thus can decrease the intracellular Ca2+concentration ([Ca2+]i) transient. Both effects can contribute to the observed negative inotropic effects of S1P. In summary, these findings suggest that the negative inotropy observed in S1P-treated adult mouse ventricular myocytes may consist of two distinctive components: 1) one pathway that acts via Gito reduce L-type calcium channel current, blunt calcium-induced calcium release, and decrease [Ca2+]i; and 2) a second pathway that acts via Gito activate IKAChand reduce APD. This decrease in APD is expected to decrease Ca2+influx and reduce [Ca2+]iand myocyte contractility.Keywords
This publication has 54 references indexed in Scilit:
- Sphingosine-1-phosphate effects on guinea pig atrial myocytes: Alterations in action potentials and K+ currentsCardiovascular Research, 2006
- Effects of L-type Ca2+ channel modulation on direct myocardial effects of diazepam and midazolam in adult rat ventricular myocytesJournal of Anesthesia, 2006
- S1P1-Selective In Vivo-Active Agonists from High- Throughput Screening: Off-the-Shelf Chemical Probes of Receptor Interactions, Signaling, and FateChemistry & Biology, 2005
- Artifactual contractions triggered by field stimulation of cardiomyocytesJournal of Applied Physiology, 2005
- The Sphingosine-1-phosphate Receptors S1P1, S1P2, and S1P3 Function Coordinately during Embryonic AngiogenesisJournal of Biological Chemistry, 2004
- Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart RateJournal of Biological Chemistry, 2004
- Modulation of myocardial contractility by lysophosphatidic acid (LPA)Journal of Molecular and Cellular Cardiology, 2003
- Characterization of G-protein Signaling in Ventricular Myocytes From the Adult Mouse Heart: Differences From the RatJournal of Molecular and Cellular Cardiology, 2000
- The relation between changes in myocyte orientation and contractile function with electrical field stimulationBasic Research in Cardiology, 1997
- The Peptide Components of Bee VenomEuropean Journal of Biochemistry, 1976